Reflections on Procedural Barriers to Pediatric COVID Vaccine Access
Bill of Health
FEBRUARY 8, 2022
By Fatima Khan. When news broke last week that Pfizer-BioNTech was submitting for Emergency Use Authorization (EUA) a two-dose COVID vaccine regimen for children under 5 to the U.S. Food and Drug Administration (FDA), many parents felt a glimmer of hope after a long time. Up until a few days before, the public was expecting approval to possibly drag into summer.
Let's personalize your content